The history of this research
This statement is by Dr. J.J. Hadlock, DAOM, LAc
In mid-December, 2019, before COVID-19 was on the American radar, and several times again in January, 2020, I saw patients with a “really stubborn flu” that “just wouldn’t go away.” My home area, the San Francisco Bay Area, was one of the first areas in the United States to see significant numbers of COVID patients.
All of these patients had the exact same three channel disruptions: on the elbow at LI-11, the mid-back at Du-9, and in the mid-brain along the Du channel.
All three of them had an unusual response immediately after I treated these three areas: as the midbrain section of the Du channel began flowing correctly, they each exclaimed something like, “I’m back!” or “It’s gone!”
At the time, I was alarmed. All successful viruses are able to disable the human electrical system in some manner. Each type of virus, each year’s “flu,” has its signature location of disruption. Most years, the current virus for that year merely affects one location, in one of the electrical currents that regulate the shoulders, knees, neck, or arms. A person might feel achy in the affected area even before they know they are sick. The disruption weakens the immune response. The virus has time to incubate unmolested. Eventually, the virus is present in large enough numbers that the immune system becomes aware of the invader in spite of the electrical disruption. When this happens, a quick, body-wide self-protection response such as fever and phlegm, in addition to a white-cell immune response, should kick in.
However, the people I saw in late 2019 and early 2020 had not one, but three electrical aberrations.
Not only did they have three, but two of the three were on the crucial electrical current that runs up the back and through the brain to the forehead: the Du channel.
Anytime a virus’s de-stabilization system operates on the Du channel, that year’s flu will be much worse than usual. For example, in 2017, when the blockage occurred in the mid-back, around Du-8, nearly twice as many people died of flu compared to an average year.
But even worse, the “flu” I was seeing in my late 2019/early 2020 patients also disrupted the midbrain at a crucial area, an area that contributes to the control of the autonomic nervous system: the system that regulates key life-sustaining factors such as temperature regulation, breathing, and heart rate.
I said out loud to all of my “three-blockage flu” patients, “I’m really worried. If this is the flu for 2020, lots more people than usual are going to die.”
As the COVID symptoms became internationally recognized as being caused by a virus, I realized that my patients who’d had symptoms characteristic of COVID were also the ones with the same three blockages. To test my theory, I wrote up a protocol for treating these three locations and sent it to an acupuncturist colleague in England. She had friends who were acupuncturists as well as being nurses, working in the local hospital. The nurses secretly performed the self-treatment (acupressure) protocol on their sickest COVID-19 patients, including patients who were waiting for respirators. The next morning, all the patients that had received this treatment were discharged from the hospital, feeling well enough that they could finish recovering at home – including the ones that had been waiting for respirators.
Encouraged by this overseas replication, I wrote up the protocol and emailed it to the United States National Institutes of Health (NIH) in June of 2020. The NIH sent a reply email thanking me for my transmission and said they were forwarding it to the National Center for Complimentary and Integrative Medicine (NCCIM). I did not hear from them again until December of 2022.
Although there was no actual federal statute, the media promoted the idea that it was illegal to promote a treatment for COVID-19 that had not been approved by the NIH. Because of this presumed law, I did not promote the treatment I’d come up with other than putting the information on my personal website. I relied on word of mouth to bring people to my website, but I did not promote it.
After nearly three years, I was extremely frustrated. Millions of people had died, many maybe unnecessarily – because this treatment actually works. Many millions more were suffering from Long-COVID, also maybe unnecessarily – because this treatment actually works. I sent emails regularly to the Health sections of every major USA newspaper. I never received a reply. Not one. No doubt, they were trying to follow the vague governmental guidelines about not promoting a COVID treatment that had not been approved.
So I decided to lecture overseas, in countries that did not follow the USA guidelines.
In Africa, I ran into no objections to my teaching this treatment. In Australia, even though they had the toughest anti-visitor laws in the world at the time, I was given a special visa to come and lecture about this treatment for COVID and Long-Covid.
The editor of the top-ranked, English language, peer-reviewed journal in my field, The Journal of Chinese Medicine, got wind of my lecture tour and asked me to write up an article on the treatment results in the classes. The article was released in October of 2022 as the lead article. Also, because of its public service nature, the article was selected as the one article from that issue that could be accessed for free, by anyone:
After the article came out and I still hadn’t heard a word from the NIH’s NCCIM, I grew increasingly frustrated. Finally, in early December, 2022, I contacted the office of my congressional representative. They sent me a “gateway” email address to the NCCAM. I wrote to this address asking what I needed to do to be allowed, legally, to promote my COVID findings, findings that I had submitted more than three years earlier. I mentioned the help I had gotten from my congressman’s office. Within two hours, I had a reply from the NCCIM.
The respondent wrote, among other things: “We encourage you to share your peer-reviewed, published research with your students, patients, and any audience.” The email encouraged me to apply to the CDC, to get my treatment posted on the CDC website.
I had their permission to go public with my findings!
Two weeks later, I received an almost effusive email from the NCCIM saying, twice, “Thank you again…! Also, “We have forwarded your research to our senior scientists who are working on COVID. Thank you again!”
It felt to me as if someone at NCCIM had finally tested the treatment on someone with Long-Covid and had been shocked by the rapid, lasting results. This second email also recommended that I apply to the FDA (Food and Drug Administration) for their approval, as well. I did not know that physical treatments such as massage or acupressure were under the jurisdiction of the FDA, but the NIH’s NCCIM encouraged me to contact them, as well. Clearly, the people at the NIH want me to do whatever I can to make this treatment information widely available.
This website is my response.